(5E)-5-[(9aS)-1-methyl-4,6,7,8,9,9a-hexahydroquinolizin-3-ylidene]pentan-2-ol

C15H25NO — CID 101385673

IUPAC(5E)-5-[(9aS)-1-methyl-4,6,7,8,9,9a-hexahydroquinolizin-3-ylidene]pentan-2-ol
SMILESCC1=C/C(=C\CCC(C)O)CN2CCCC[C@@H]12
InChIInChI=1S/C15H25NO/c1-12-10-14(7-5-6-13(2)17)11-16-9-4-3-8-15(12)16/h7,10,13,15,17H,3-6,8-9,11H2,1-2H3/b14-7+/t13?,15-/m0/s1
InChIKeyAHEJLXVLILVPHL-WQWYEDORSA-N
MW235.37 g/mol
LogP2.89
Rot. Bonds3

About (5E)-5-[(9aS)-1-methyl-4,6,7,8,9,9a-hexahydroquinolizin-3-ylidene]pentan-2-ol

(5E)-5-[(9aS)-1-methyl-4,6,7,8,9,9a-hexahydroquinolizin-3-ylidene]pentan-2-ol (PubChem CID 101385673) has the molecular formula C15H25NO and a molecular weight of 235.37 g/mol. Its IUPAC name is (5E)-5-[(9aS)-1-methyl-4,6,7,8,9,9a-hexahydroquinolizin-3-ylidene]pentan-2-ol.

Molecular Properties

Compound Name(5E)-5-[(9aS)-1-methyl-4,6,7,8,9,9a-hexahydroquinolizin-3-ylidene]pentan-2-ol
PubChem CID101385673
Molecular FormulaC15H25NO
Molecular Weight235.37 g/mol
Exact Mass235.19
IUPAC Name(5E)-5-[(9aS)-1-methyl-4,6,7,8,9,9a-hexahydroquinolizin-3-ylidene]pentan-2-ol
SMILESCC1=C/C(=C\CCC(C)O)CN2CCCC[C@@H]12
InChIInChI=1S/C15H25NO/c1-12-10-14(7-5-6-13(2)17)11-16-9-4-3-8-15(12)16/h7,10,13,15,17H,3-6,8-9,11H2,1-2H3/b14-7+/t13?,15-/m0/s1
InChIKeyAHEJLXVLILVPHL-WQWYEDORSA-N
XLogP2.89
TPSA23.47 Ų
H-Bond Donors1
H-Bond Acceptors2
Rotatable Bonds3
Heavy Atoms17
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500235.37
LogP ≤ 52.89
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 102

Analyze (5E)-5-[(9aS)-1-methyl-4,6,7,8,9,9a-hexahydroquinolizin-3-ylidene]pentan-2-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Microgrewiapine A
CID 71576920
Cryptophorine
CID 5281684
(2R,3R,6R)-6-[(1E,3E,5E,7E)-deca-1,3,5,7-tetraenyl]-1,2-dimethylpiperidin-3-ol
CID 101821061
(2S,5E)-5-[(9aR)-1-methyl-4,6,7,8,9,9a-hexahydroquinolizin-3-ylidene]pentan-2-ol
CID 15939795
5-(1-Methyl-4,6,7,8,9,9a-hexahydroquinolizin-3-ylidene)pentan-2-ol
CID 73201034
(Z)-5-((S)-9-Methyl-3,4-dihydro-1H-quinolizin-7(2H,6H,9aH)-ylidene)pentan-2-ol
CID 91735640
1-(Cyclohexa-1,5-dien-1-ylmethyl)-2-ethylpiperidin-4-ol
CID 87674939
1-[1-(6-Hydroxycyclohexa-1,5-dien-1-yl)ethyl]piperidin-4-ol
CID 89688751
1-(1-Cyclohexa-1,5-dien-1-yl-2-hydroxyethyl)piperidin-4-ol
CID 90711064
1,7-dimethyl-3,4,8,8a-tetrahydro-2H-quinolin-2-ol
CID 144078848
1-[(5E,7E)-5,8-dimethyl-4-methylidenedeca-5,7-dienyl]piperidin-4-ol
CID 144394058
1-(Cyclohexa-1,5-dien-1-ylmethyl)-2,2,6,6-tetramethylpiperidin-4-ol
CID 153368737

Frequently Asked Questions

What is the IUPAC name of (5E)-5-[(9aS)-1-methyl-4,6,7,8,9,9a-hexahydroquinolizin-3-ylidene]pentan-2-ol?
The IUPAC name of (5E)-5-[(9aS)-1-methyl-4,6,7,8,9,9a-hexahydroquinolizin-3-ylidene]pentan-2-ol (CID 101385673) is (5E)-5-[(9aS)-1-methyl-4,6,7,8,9,9a-hexahydroquinolizin-3-ylidene]pentan-2-ol.
What is the SMILES notation for (5E)-5-[(9aS)-1-methyl-4,6,7,8,9,9a-hexahydroquinolizin-3-ylidene]pentan-2-ol?
The canonical SMILES for (5E)-5-[(9aS)-1-methyl-4,6,7,8,9,9a-hexahydroquinolizin-3-ylidene]pentan-2-ol is CC1=C/C(=C\CCC(C)O)CN2CCCC[C@@H]12.
What is the InChIKey of (5E)-5-[(9aS)-1-methyl-4,6,7,8,9,9a-hexahydroquinolizin-3-ylidene]pentan-2-ol?
The InChIKey is AHEJLXVLILVPHL-WQWYEDORSA-N. The full InChI is InChI=1S/C15H25NO/c1-12-10-14(7-5-6-13(2)17)11-16-9-4-3-8-15(12)16/h7,10,13,15,17H,3-6,8-9,11H2,1-2H3/b14-7+/t13?,15-/m0/s1.
What are the key properties of (5E)-5-[(9aS)-1-methyl-4,6,7,8,9,9a-hexahydroquinolizin-3-ylidene]pentan-2-ol?
(5E)-5-[(9aS)-1-methyl-4,6,7,8,9,9a-hexahydroquinolizin-3-ylidene]pentan-2-ol has a molecular weight of 235.37 g/mol, XLogP of 2.89, 3 rotatable bonds, 1 hydrogen bond donors, and 2 hydrogen bond acceptors.
Where does this data come from?
All data for (5E)-5-[(9aS)-1-methyl-4,6,7,8,9,9a-hexahydroquinolizin-3-ylidene]pentan-2-ol is sourced from PubChem (CID 101385673), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).